In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019

ABSTRACT Cefiderocol was evaluated by broth microdilution versus 1,050 highly antimicrobial-resistant Pseudomonas aeruginosa clinical isolates from the CANWARD study (2007 to 2019). Overall, 98.3% of isolates remained cefiderocol susceptible (MIC, ≤4 μg/mL), including 97.4% of extensively drug-resis...

Full description

Bibliographic Details

Published in:	Microbiology Spectrum
Main Authors:	James A. Karlowsky, Andrew J. Walkty, Melanie R. Baxter, Heather J. Adam, Philippe R. S. Lagacé-Wiens, Frank Schweizer, Denice Bay, Joseph P. Lynch, Michael R. Mulvey, George G. Zhanel
Format:	Article
Language:	English
Published:	American Society for Microbiology 2022-08-01
Subjects:	antibacterial bacterial cephalosporin susceptibility
Online Access:	https://journals.asm.org/doi/10.1128/spectrum.01724-22